Get the Stockscreener App
2.93
3.30%
-0.10
After Hours:
2.93
Ac Immune Sa stock is traded at $2.93, with a volume of 247.37K.
It is down -3.30% in the last 24 hours and down -16.76% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$3.03
Open:
$3.03
24h Volume:
247.37K
Relative Volume:
0.38
Market Cap:
$294.76M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-4.1297
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
-1.01%
1M Performance:
-16.76%
6M Performance:
+36.28%
1Y Performance:
+21.07%
1-Day Range:
$2.88
$3.04
1-Week Range:
$2.88
$3.19
52-Week Range:
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.93 | 304.82M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Bank Watch: Does AC Immune SA outperform in volatile marketsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Earnings Beat: Should I trade or invest in CVLGJuly 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn
Aug Analyst Calls: Can AC Immune SA weather a recession2025 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
AC Immune (NASDAQ:ACIU) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Can AC Immune SA weather a recession2025 Valuation Update & Weekly Watchlist for Consistent Profits - mfd.ru
Does AC Immune SA outperform in volatile markets2025 Valuation Update & Weekly High Conviction Ideas - mfd.ru
What is AC Immune SA s revenue forecastWeekly Earnings Recap & Free Accurate Trade Setup Notifications - mfd.ru
Will AC Immune SA outperform its industry peersQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Performance Recap: Is Stagwell Inc stock forming a cup and handleGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
Dip Buying: Should I buy AC Immune SA stock nowJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
Will AC Immune SA outperform the market in YEAR2025 Key Highlights & High Win Rate Trade Alerts - Mfd.ru
AC Immune (NASDAQ:ACIU) Stock Price Down 5.4%Time to Sell? - MarketBeat
Profit Recap: Will AC Immune SA outperform its industry peersIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
Aug Outlook: Will AC Immune SA outperform its industry peersStock Surge & Real-Time Volume Analysis - baoquankhu1.vn
Fed Meeting: Will AC Immune SA outperform its industry peers2025 Market Sentiment & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Risk Off: Why AC Immune SA stock attracts global investors2025 Bull vs Bear & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
Top Penny Stocks To Watch In January 2026 - Yahoo Finance
Trading Recap: Can AC Immune SA stock deliver surprise earnings beatEarnings Overview Report & AI Based Buy/Sell Signal Reports - Bộ Nội Vụ
What insider purchases suggest about AC Immune SA (IMR) stockJuly 2025 Breakouts & Growth Focused Stock Reports - Улправда
What valuation ratios show for AC Immune SA (IMR) stockJuly 2025 Final Week & Weekly High Potential Alerts - Улправда
How AC Immune SA stock benefits from tech adoption2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
How AC Immune SA stock performs after earningsNew Guidance & Expert-Curated Trade Recommendations - ulpravda.ru
Can AC Immune SA stock beat market expectations this quarterMarket Growth Summary & Fast Entry Momentum Trade Alerts - Улправда
Will AC Immune SA stock split again soon2025 EndofYear Setup & Short-Term Trading Alerts - ulpravda.ru
Risk Check: What hedge fund activity signals for AC Immune SA stock2025 Year in Review & Verified Technical Signals - Улправда
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - MSN
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Yahoo Finance
Why is AC Immune stock up over 23% today? - MSN
Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4% - MarketBeat
Assenagon Asset Management S.A. Purchases New Position in AC Immune $ACIU - Defense World
Market Leaders: Will AC Immune SA stock split again soonMarket Trend Review & High Return Stock Watch Alerts - moha.gov.vn
AC Immune (STU:IMR) EV-to-OCF : -3.79 (As of Jan. 06, 2026) - GuruFocus
AC Immune (NASDAQ:ACIU) Trading Up 5%Should You Buy? - MarketBeat
Why ETFs are accumulating AC Immune SA (IMR) stockTechnical Breakout Signals & Free High Impact Stock Picks - bollywoodhelpline.com
Why AC Immune SA stock remains a top recommendationPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
New Highs: Will AC Immune SA stock recover faster than marketWeekly Investment Summary & Real-Time Volume Trigger Notifications - Улправда
How AC Immune SA stock responds to policy changesPortfolio Return Report & Daily Profit Maximizing Tips - Улправда
Why analysts upgrade AC Immune SA stock2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Will AC Immune SA (IMR) stock boost dividends further2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Should I hold or sell AC Immune SA stock in 2025Market Performance Report & Consistent Income Trade Recommendations - DonanımHaber
Is AC Immune SA stock supported by strong fundamentals2025 Bull vs Bear & Free Community Consensus Stock Picks - Bölüm Sonu Canavarı
Recap Report: Why analysts upgrade AC Immune SA stockWeekly Investment Summary & Growth Oriented Trading Recommendations - ulpravda.ru
Will AC Immune SA stock outperform Dow Jones indexPortfolio Update Report & Reliable Entry Point Alerts - ulpravda.ru
Aug Update: Will AC Immune SA stock recover faster than market2025 Market Sentiment & Safe Capital Allocation Plans - Улправда
AC Immune (STU:IMR) OCF Margin % : -1,953.03% (As of Sep. 2025) - GuruFocus
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn
Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn
AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):